GlassScriptPhysician profile
Amanda L Johnson
NPI 1508374174
$3,539.28
in general payments reported to CMS, 2019-2025
18 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $620 · 2022: $650 · 2023: $1,311 · 2024: $765 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,024 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.98 |
| Education | $245.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $694.69 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $648.74 | 2021-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $448.80 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $440.83 | 2021-2024 | Tezspire, Fasenra, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $298.89 | 2022-2024 | Cuvitru, Hyqvia, Glassia |
| Sanofi-Aventis U.S. LLC | $198.94 | 2023-2024 | |
| Abbvie INC. | $159.25 | 2025 | |
| Genentech USA, INC. | $150.05 | 2021-2024 | Xolair |
| Csl Behring | $82.60 | 2021-2025 | Kcentra |
| Grifols USA, LLC | $81.66 | 2022-2023 | Prolastin-C Liquid, Xembify |
| Amgen INC. | $68.04 | 2021-2023 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $67.02 | 2021 | |
| Kaleo, INC. | $62.26 | 2021-2022 | |
| Alkermes, INC. | $59.63 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.46 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.90 | 2023 | |
| Optinose US, INC. | $18.59 | 2021 | |
| Pfizer INC. | $15.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.